Picture courtesy The News Minute
New Delhi: Bharat Biotech-developed vaccine candidate COVAXIN will be affective on mutant strains of the novel coronavirus, the company expressed confidence at a press conference on Monday.
According to Bharat Biotech chairman and managing director, Dr Krishna Ella, the company will be able to establish the “hypothesis” of the candidate’s ability to protect against mutations in a week.
“It’s only a hypothesis right now…but just give me one week’s time (and) I’ll give confirmatory data,” Dr Ella was quoted as saying by The Indian Express.
He was responding to a query on whether there were data to show Covaxin is effective against the mutant strain of the SARS-CoV-2 virus. The second strain was first detected in the United Kingdom and has since been found in over 30 other countries.
ALSO READ: Covaxin 200% Safe, Says Bharat Biotech MD After Backlash On Vaccine Efficacy
Rourkela: Five persons were arrested by the police for allegedly running a betting racket during…
New Delhi: The Maharashtra Cyber Cell has summoned actress Tamannaah Bhatia in the illegal IPL…
Boudh: Two Maoists were killed early on Thursday in a gun battle with security forces…
Bhubaneswar: A day after Naveen Patnaik set the BJD's poll pitch for upcoming Lok Sabha…
Bhubaneswar: Biju Janata Dal (BJD) on Wednesday moved the Election Commission of India (ECI) accusing…
New Delhi: Is Sobhita Dhulipala dating Samantha Ruth Prabhu’s ex-husband Naga Chaitanya? Sobhita, who has starred…
Bhubaneswar: Announcing yet another replacement of nominee for the upcoming elections in Odisha, Congress changed…
Bhubaneswar: The Indian senior men’s football team will prepare for next month’s crucial World Cup qualifiers…